Asia Pacific Microneedle Drug Delivery Systems Market Size

Asia Pacific Microneedle Drug Delivery Systems Market Size 2027

Asia Pacific Microneedle Drug Delivery Systems Market By Type (Hollow, Dissolving, Solid, Coated, and Other Types), By Material (Metal, Polymer, Silicon and Other Material), By Application (Drug delivery, Cancer Therapy, Vaccine delivery, Pain Management, Dermatology and Other Applications), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : November-2021 | Number of Pages : 92 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the Asia Pacific Microneedle Drug Delivery Systems Market

Market Report Description

The Asia Pacific Microneedle Drug Delivery Systems Market would witness market growth of 9.2% CAGR during the forecast period (2021-2027).

Microneedles are smaller needles that are developed to deliver medicines inside a patient’s body. These microneedles offer several benefits for biological agents in comparison to traditional syringe and needle delivery systems. As microneedle is extensively used for the delivery of drugs, it is playing a crucial role in the medical, biotechnology, and pharmaceutical industries. Moreover, microneedles have found its applications across various medical fields like dermatology, oncology, cardiovascular, and neurology.

Factors such as ever-increasing population, drug administration transdermal & intradermal drug delivery systems, and early phase disease diagnosis & treatment are expected to create lucrative growth opportunities for the market. Moreover, high per capita health care expenditure is likely to unlock growth prospects for the microneedle drug delivery systems market during the coming years.

The microneedle drug delivery systems market is anticipated to witness significant growth in Asia-Pacific. As many of the countries of the region were hit hard by the outbreak of the COVID-19 pandemic, microneedle drug delivery systems played a pivotal role in the treatment of the COVID-19 infection-associated malnutrition in patients across the world.

Moreover, the increase in the occurrence of chronic disorders like cancer, Crohn’s disease, HIV, and others are expected to fuel the growth of the regional microneedle drug delivery systems market during the forecasting period. Furthermore, numerous premature babies get nutrition delivered using microneedles. Intravenous solutions have been a crucial component of the healthcare system of many countries, allowing doctors & nurses to provide hydration to their patients, substitute loss of blood volume, and administer drugs. Therefore, these factors are set to boost the demand for microneedle drug delivery systems in the regional market.

The China market dominated the Asia Pacific Silicon Market by Country in 2020, thereby, achieving a market value of $151.9 million by 2027. The Japan market is showcasing a CAGR of 9.7% during (2021 - 2027). Additionally, The India market is anticipated to grow at a CAGR of 9.7% during (2021 - 2027).

Based on Type, the market is segmented into Hollow, Dissolving, Solid, Coated, and Other Types. Based on Material, the market is segmented into Metal, Polymer, Silicon and Other Material. Based on Application, the market is segmented into Drug delivery, Cancer Therapy, Vaccine delivery, Pain Management, Dermatology and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Microneedle Drug Delivery Systems Market is Projected to reach USD 9.1 Billion by 2027, at a CAGR of 7.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AdminMed nanoBioSciences LLC, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Technologies Ltd., Corium International, Inc., Gurnet Point Capital), Valeritas, Inc. (Zealand Pharma), Nitto Denko Corporation, Endoderma Ltd., and Innoture Medical Technology Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Hollow
  • Dissolving
  • Solid
  • Coated,
  • Other Types

By Material

  • Metal
  • Polymer
  • Silicon
  • Other Material

By Application

  • Drug delivery
  • Cancer Therapy
  • Vaccine delivery
  • Pain Management
  • Dermatology
  • Other Applications

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • AdminMed nanoBioSciences LLC
  • Becton, Dickinson and Company
  • Zosano Pharma Corporation
  • Raphas co. ltd.
  • Nanopass Technologies Ltd.
  • Corium International, Inc. (Gurnet Point Capital)
  • Valeritas, Inc. (Zealand Pharma)
  • Nitto Denko Corporation
  • Endoderma Ltd.
  • Innoture Medical Technology Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Microneedle Drug Delivery Systems Market Report 2021-2027

North America Microneedle Drug Delivery Systems Market Report 2021-2027

Europe Microneedle Drug Delivery Systems Market Report 2021-2027

LAMEA Microneedle Drug Delivery Systems Market Report 2021-2027

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities